Evidence map›Paper›PMID 25287853›Full record

Trial reportImplementation science : IS2014

Optimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trial.

Christin Löffler, Eva Drewelow, Susanne D Paschka, Martina Frankenstein, Julia Eger, Lisa Jatsch, Emil C Reisinger, Johannes F Hallauer, Bernd Drewelow, Karen Heidorn and 5 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Implementation science : IS, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Discharge planning from hospital.The Cochrane database of systematic reviews · 2022
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Discharge planning from hospital.The Cochrane database of systematic reviews · 2016
    Pooled it
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Christin LöfflerInstitute of General Practice, Rostock University Medical Center, Rostock, Germany. christin.loeffler@med.uni-rostock.de.
Eva DrewelowInstitute of General Practice, Rostock University Medical Center, Rostock, Germany. eva.drewelow@med.uni-rostock.de.
Susanne D PaschkaHospital Pharmacy, Rostock University Medical Center, Rostock, Germany. susanne.paschka@med.uni-rostock.de.
Martina FrankensteinHospital Pharmacy, Rostock University Medical Center, Rostock, Germany. martina.frankenstein@med.uni-rostock.de.
Julia EgerInstitute of General Practice, Rostock University Medical Center, Rostock, Germany. julia.eger@med.uni-rostock.de.
Lisa JatschInstitute of General Practice, Rostock University Medical Center, Rostock, Germany. lisa.jatsch@med.uni-rostock.de.
Emil C ReisingerDepartment of Internal Medicine II, Rostock University Medical Center, Rostock, Germany. emil.reisinger@med.uni-rostock.de.
Johannes F HallauerDietrich-Bonhoeffer Hospital, Neubrandenburg, Germany. HallauerJ@dbknb.de.
Bernd DrewelowInstitute of Pharmacology, Rostock University Medical Center, Rostock, Germany. bernd.drewelow@med.uni-rostock.de.
Karen HeidornHospital Pharmacy, Rostock University Medical Center, Rostock, Germany. karen.heidorn@med.uni-rostock.de.
Helmut SchröderAOK Scientific Institute (WIdO), Berlin, Germany. helmut.schroeder@wido.bv.aok.de.
Anja WollnyInstitute of General Practice, Rostock University Medical Center, Rostock, Germany. anja.wollny@med.uni-rostock.de.
Günther KundtInstitute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany. guenther.kundt@uni-rostock.de.
Christian SchmidtRostock University Medical Center, Rostock, Germany. christian.schmidt@med.uni-rostock.de.
Attila AltinerInstitute of General Practice, Rostock University Medical Center, Rostock, Germany. altiner@med.uni-rostock.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTreatment of patients with multimorbidity is challenging. A rational reduction of long-term drugs can lead to decreased mortality, less acute hospital treatment, and a reduction of costs. Simplification of drug treatment schemes is also related to higher levels of patient satisfaction and adherence. The POLITE-RCT trial will test the effectiveness of an intervention aiming at reducing the number of prescribed long-term drugs among multimorbid and chronically ill patients. The intervention focuses on the interface between primary and secondary health care and includes a pharmacist-based, patient-centered medication review prior to the patient's discharge from hospital.

methodsThe POLITE-RCT trial is a cluster randomized controlled trial. Two major secondary health care providers of Mecklenburg-Western Pomerania, Germany, take part in the study. Clusters are wards of both medical centers. All wards where patients with chronic diseases and multimorbidity are regularly treated will be included. Patients aged 65+ years who take five or more prescribed long-term drugs and who are likely to spend at least 5 days in the participating hospitals will be recruited and included consecutively. Cluster-randomization takes place after a six-month baseline data collection period. Patients of the control group receive care as usual. The independent two main primary outcomes are (1) health-related quality of life (EQ-5D) and (2) the difference in the number of prescribed long-term pharmaceutical agents between intervention and control group. The secondary outcomes are appropriateness of prescribed medication (PRISCUS list, Beers Criteria, MAI), patient satisfaction (TSQM), patient empowerment (PEF-FB-9), patient autonomy (IADL), falls, re-hospitalization, and death. The points of measurement are at admission to (T0) and discharge from hospital (T1) as well as 6 and 12 months after discharge from the hospital (T2 and T3). In 42 wards, 1,626 patients will be recruited. DISCUSSION: In case of positive evaluation, the proposed study will provide evidence for a sustainable reduction of polypharmacy by enhancing patient-centeredness and patient autonomy.

trial registrationCurrent Controlled Trials ISRCTN42003273.

Indexed as

PolypharmacyAgedChronic DiseaseCluster AnalysisGermanyHospitalizationHumansLong-Term CarePatient SatisfactionPrescription DrugsPrescription Drugs

Identifiers

PMID25287853
PMCPMC4192341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.